Loviride is an experimental antiviral drug, a non-nucleoside reverse transcriptase inhibitor (NNRTI), developed to treat HIV infections by blocking the virus’s ability to replicate, though it didn’t get market approval due to low potency, remaining significant mainly in clinical research for studying drug resistance. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Lovirida and Loviridum. Its PubChem CID is 3963.
Loviride
| CAS No | 147362-57-0 |
|---|---|
| Molecular Formula | C17H16Cl2N2O2 |
| Molecular Weight | 351.20g/mol |
| Synonyms | 2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Loviride is an experimental antiviral drug, a non-nucleoside reverse transcriptase inhibitor (NNRTI), developed to treat HIV infections by blocking the virus's ability to replicate, though it didn't get market approval due to low potency, remaining significant mainly in clinical research for studying drug resistance.
The listed CAS number is 147362-57-0.
The listed molecular formula is C17H16Cl2N2O2.
The listed molecular weight is 351.20g/mol.
2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide.
The source lists Lovirida and Loviridum.